Investment Analysts’ Weekly Ratings Changes for McKesson (MCK)

McKesson (NYSE: MCK) has recently received a number of price target changes and ratings updates:

• 8/11/2026 – McKesson had its price target raised by Wells Fargo & Company from $812.00 to $933.00. They now have an “equal weight” rating on the stock.
• 8/7/2026 – McKesson had its “overweight” rating reaffirmed by Morgan Stanley.
• 8/6/2026 – McKesson was given a new $1,015.00 price target by Robert W. Baird.
• 8/6/2026 – McKesson had its “outperform” rating reaffirmed by Evercore Inc.
• 8/6/2026 – McKesson had its price target raised by TD Cowen from $989.00 to $1,006.00. They now have a “buy” rating on the stock.
• 8/6/2026 – McKesson had its price target raised by UBS Group AG from $1,050.00 to $1,080.00. They now have a “buy” rating on the stock.
• 7/24/2026 – McKesson had its price target raised by Citigroup Inc. from $945.00 to $1,000.00. They now have a “buy” rating on the stock.
• 7/21/2026 – McKesson had its price target lowered by TD Cowen from $1,012.00 to $989.00. They now have a “buy” rating on the stock.
• 7/7/2026 – McKesson was downgraded by Weiss Ratings from “buy (b)” to “buy (b-)”.
• 6/27/2026 – McKesson was downgraded by Wall Street Zen from “buy” to “hold”.

McKesson Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Tuesday, September 1st will be issued a dividend of $0.94 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $3.76 annualized dividend and a yield of 0.4%. This is a positive change from McKesson’s previous quarterly dividend of $0.82. McKesson’s dividend payout ratio (DPR) is currently 8.78%.

Insider Transactions at McKesson

In other news, EVP Thomas L. Rodgers sold 2,388 shares of the business’s stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $761.09, for a total transaction of $1,817,482.92. Following the completion of the sale, the executive vice president owned 3,090 shares in the company, valued at $2,351,768.10. The trade was a 43.59% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Michele Lau sold 3,550 shares of the company’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $761.09, for a total value of $2,701,869.50. Following the transaction, the executive vice president directly owned 3,247 shares in the company, valued at $2,471,259.23. This trade represents a 52.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 29,049 shares of company stock worth $22,530,626. Corporate insiders own 0.06% of the company’s stock.

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.